CXCR2 and glioblastoma: have demonstrated that overexpression of programmed cell death protein 10 (PDCD10) promotes the release of CXCL2 and activates CXCR2 and ERK1/2-mediating signaling, thereby recruiting and activating BRM/macrophages to promote the GBM progression (63).